தினமலர் டிவி
Podcast
iPaper
சினிமா
கோயில்கள்
புத்தகங்கள்
Subscription
திருக்குறள்
கடல் தாமரை
/
செய்திகள்
/
Kalvimalar
/
News
/
Avay Biosciences launches 3D printer capable of printing human tissues
/
Avay Biosciences launches 3D printer capable of printing human tissues
Avay Biosciences launches 3D printer capable of printing human tissues
Avay Biosciences launches 3D printer capable of printing human tissues
UPDATED : ஜன 01, 1970 05:30 AM
ADDED : நவ 22, 2022 12:00 AM
நிறம் மற்றும் எழுத்துரு அளவு மாற்ற
Bangalore: Indian Tech Start-up Avay Biosciences has launched ‘Mito Plus,’ an indigenous state-of-the-art Bio 3D Printer that can print human tissues.
Bioprinting is a method of Tissue Replication that uses ‘bioinks’ which are engineered to print artificial living tissues like skin used during bioprinting.
Bioprinting temporarily or permanently supports and nurtures living cells. The first prototype of Mito Plus was installed at Indian Institute of Science, Bangalore, the top ranked Science Research institute by NIRF Rankings.
Mito Plus was launched during the Bengaluru Tech Summit, which is being held between 16th and 18th November 2022.
Mito Plus is the advanced version of the Bio 3D printer developed with inputs on the prototype from the research lab of Dr Bikramjit Basu at IISc, and developed by Avay which was co-founded by an IIT Madras Alumnus. It is one of the advanced 3D Bioprinters in India. Avay Biosciences provides completely indigenous development of both software and hardware for end-to-end Bio 3D Printing Solutions in India.
The start-up is already partnering with premier Research and Development institutes across India including IIT Madras, Institute of Chemical Technology (ICT), Mumbai, National Institute of Pharmaceutical Education And Research (NIPER), Hyderabad, and BITS Pilani (Goa Campus) as customers and collaborators.
According to various bioprinting market reports, the global 3D bioprinting market is currently valued at USD 1.3 billion as of 2022 and is projected to reach USD 3.3 billion by 2027. There is a huge demand seen in the pharmaceutical and cosmetology industries.
Bioprinters work in almost the exact same way as other 3d printers do, with one major difference i.e instead of delivering materials such as plastic, metal or powders , bioprinters deposit layer of biomaterials, that may include living cells, to build complex structures like skin tissue, liver tissue etc. 
3D bioprinting is a unique gift to humanity by science and technology.
Although there are many challenges that are yet to be solved. There is still a long way to go before we can create fully functioning and viable organs for human transplant.
Advertisement